Reaction

Pneumatosis Intestinalis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,802 reports · 129 co-occurring drugs

As of the last recalculation, Pneumatosis Intestinalis appears in 2,802 FAERS reports alongside 129 co-occurring drug terms. The strongest observed disproportionality signal is PEGASPARGASE (PRR 90.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Pegaspargase	142	90.7	91.8
Mercaptopurine	142	64.0	64.5
Vincristine Sulfate	138	36.7	36.9
Rifampin	68	35.4	35.6
Filgrastim	135	28.0	28.1
Sirolimus	46	25.8	25.9
Tacrolimus Ointment 0.1%	364	24.8	24.9
Tacrolimus Extended-Release Capsules	364	24.7	24.8
Cytarabine	186	24.6	24.6
Methylprednisolone	390	24.2	24.3
Tacrolimus	422	23.4	23.4
Mesna	24	21.3	21.4
Mesna Injection	23	20.8	20.9
Etoposide	192	20.8	20.8
Fludarabine Phosphate	101	19.8	19.8
Cetuximab	81	19.7	19.8
Erlotinib	24	18.6	18.6
Mycophenolate Mofetil Hydrochloride	299	18.2	18.2
Mycophenolate Mofetil	298	18.1	18.2
Fluorouracil Cream, 0.5%	168	17.3	17.4
Fluorouracil	168	17.1	17.1
Irinotecan Hydrochloride	29	16.9	17.0
Norepinephrine	23	16.1	16.1
Anti-Itch	137	15.9	15.9
Anti-Pruritic	137	15.9	15.9
Antipruritic (Anti-Itch)	137	15.9	15.9
Cool Relief Gel With Aloe	137	15.9	15.9
Drs. Hydrocortisone	137	15.9	15.9
Hydrocortisone Continuous Spray	137	15.9	15.9
Hydrocortisone Spray	137	15.9	15.9
Anti-Itch Cream	137	15.9	15.9
Hydrocortisone Lotion	137	15.9	15.9
Hydrocortisone Cream 1%	137	15.9	15.9
Hydrocortisone Cream 1/2%	137	15.9	15.9
Hydrocortisone 1%	137	15.9	15.9
Hydrocortisone Cream	137	15.8	15.9
Methylprednisolone Sodium Succinate	95	15.7	15.7
Erlotinib Hydrochloride	26	15.6	15.6
Lactulose	78	15.5	15.5
Busulfan	32	15.3	15.3
Azithromycin	80	15.2	15.2
Hydrocortisone Acetate	137	14.7	14.7
Azithromycin Monohydrate	80	14.7	14.7
Clarithromycin	66	14.6	14.6
Leucovorin Calcium	37	14.6	14.6
Gefitinib	17	14.1	14.1
Imatinib	33	14.1	14.1
Methylprednisolone Acetate	15	14.0	14.0
Oxaliplatin	131	13.7	13.7
Norepinephrine Bitartrate	26	13.5	13.6
Prednisolone	295	13.5	13.5
Prednisolone Oral	295	13.5	13.5
Prednisolone Oral Solution	295	13.5	13.5
Hydrocortisone	139	12.1	12.1
Cyclophosphamide Injection, Solution	261	12.0	12.0
Cyclophosphamide	261	12.0	12.0
Cyclophosphamide For Injection	261	12.0	12.0
Amikacin	26	11.4	11.4
Melphalan	32	10.6	10.6
Azithromycin Dihydrate	81	10.5	10.5
Hydrocortisone Sodium Succinate	13	10.3	10.3
Cisplatin	104	10.2	10.2
Cyclosporine	144	10.1	10.1
Ampicillin	11	9.9	9.9
Ampicillin Sodium	11	9.9	9.9
Melphalan Hydrochloride	33	9.9	9.9
Mycophenilic Acid	27	9.8	9.8
Rifampicin	13	9.6	9.6
Piperacillin And Tazobactam	16	9.3	9.3
Anti-Thymocyte Globulin (Rabbit)	10	9.2	9.2
Sunitinib Malate	48	9.2	9.2
Dexamethasone Sodium Phosphate	12	8.8	8.8
Piperacillin Sodium,Tazobactam Sodium	29	8.2	8.2
Piperacillin Sodium And Tazobactam Sodium	21	8.0	8.0
Remdesivir	14	7.8	7.8
Amphotericin B	13	7.7	7.7
Docetaxel Anhydrous	68	7.7	7.7
Docetaxel	68	7.7	7.7
Lenvatinib	33	7.5	7.6
Rifaximin	21	7.5	7.5
Bevacizumab	116	7.2	7.2
Blinatumomab	10	7.1	7.1
Doxorubicin Hydrochloride	31	7.1	7.1
Doxorubicin	82	7.0	7.0
Magnesium Sulfate In Water For	12	7.0	7.0
Azathioprine	81	7.0	7.0
Magnesium Sulfate Heptahydrate	12	6.9	6.9
Magnesium Sulfate	12	6.9	6.9
Dexamethasone 1.5 Mg	246	6.7	6.7
Panitumumab	14	6.7	6.7
Dexamethasone	246	6.7	6.7
Capecitabine	80	6.7	6.7
Teduglutide	12	6.6	6.6
Axitinib	17	6.5	6.5
Nintedanib	27	6.4	6.5
Mycophenolic Acid	27	6.3	6.3
Carboplatin	104	6.3	6.3
Paclitaxel (Aibumin-Bound)	68	6.3	6.3
Cefepime	12	6.2	6.2
Polyethylene Glycol	9	6.2	6.2
Paclitaxel	76	5.8	5.8
Atezolizumab	30	5.8	5.8
Vancomycin	44	5.7	5.7
Cefepime Hydrochloride	12	5.6	5.6
Valganciclovir Hydrochloride Powder,	9	5.5	5.5
Thiotepa	7	5.5	5.5
Anakinra	12	5.4	5.4
Vancomycin Hydrochloride	47	5.4	5.4
Hydroxychloroquine	50	5.0	5.1
Pemetrexed Disodium	24	4.7	4.7
Trametinib	15	4.6	4.6
Ifosfamide	13	4.5	4.5
Cabozantinib	28	4.4	4.4
Brentuximab Vedotin	6	4.4	4.4
Bleomycin Sulfate	6	4.3	4.3
Sorafenib	12	4.3	4.3
Imatinib Mesylate	16	4.3	4.3
Temozolomide	12	4.2	4.2
Ruxolitinib	39	4.1	4.1
Pembrolizumab	52	3.7	3.7
Abiraterone	6	3.3	3.3
Pemetrexed	9	3.1	3.1
Crizotinib	5	2.9	2.9
Eltrombopag Olamine	9	2.9	2.9
Suvorexant	5	2.9	2.9
Dabrafenib	8	2.8	2.8
Nivolumab	30	2.3	2.3
Fam-Trastuzumab Deruxtecan-Nxki	3	2.2	2.2
Durvalumab	5	1.8	1.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.